Subgroup analysis showed that at diagnosis, patients with obesity (PwO) were younger (p = 0.022), had lower PSA (p = 0.016), and had lower 10-year all-cause mortality rates (p = 0.04) than patients without obesity. This evidence concerns the gene KLK3 and obesity due to melanocortin 4 receptor deficiency.